Cannabis has become one of the most innovative and disruptive industries globally with rapid growth potential. And thanks to a more progressive legislative approach in Europe. Investors are now plowing millions into the nascent cannabidiol (CBD) market.
European CBD Market Is Booming – And Investors Finally Recognize It
According to CB Insights, in 2019, CBD startups in Europe saw a record level of investment—34 innovative companies received a total of $128.5 million. Annualized activity suggests funding could continue to rise this year, approaching $150 million. “Regulatory relaxation has been the predominant driver of investment and gained momentum in 2019. Luxembourg became the first European country to announce its intent to legalize cannabis for recreational use. Investors believe a ‘domino effect’ could follow, as seen previously in North America and Asia,” says Marissa Schlueter, Senior Intelligence Analyst at CB Insights.
Read Also – Egg Roll In A Bowl: Low-Carb Meal
Read Also – Things To Do When You’re Bored | CraveMonger
European CBD Market Is Booming. A recent report by the Centre for Medical Cannabis estimates that 8-11% of U.K. adults respectively approx 4-6 million people—have tried CBD. The market size is estimated at $390 million per year and expected to be just short of $1.3 billion in 2025. This would be equivalent to the entire U.K. herbal supplement market in 2016.
Read Also – How to Stop Masturbation Addiction | Acne myth
Born out of Europe’s biggest market for CBD, Germany, Sanity Group has raised a whopping $23.7 million so far. Comprising a wellness brand VAAY, and a pharmaceutical brand Vayamed. Now, in its physical shop in the heart of Berlin. Earlier this month, VAAY released it’s first TV ad in Germany to create new, positive stories around CBD. And educate the population about the health benefits of cannabis, be it day-to-day or medical-grade.